Whitepaper: Type-1 Interferon Test For Risk Assessment

To learn more about IFN-1 and ways to identify patients that might benefit from targeted therapies, read our new white paper that discusses the:

• Increased disease severity and risks among SLE patients with high IFN-1 levels
• Correlation of IFN-1 expression to specific patient sub-populations
• Importance of IFN-1 testing in determining disease state and/or response to therapy